Eledon pharmaceuticals announces pricing of $85 million underwritten offering of common stock and pre-funded warrants

Irvine, calif., oct. 29, 2024 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn), today announced the pricing of its underwritten offering of (i) 18,356,173 shares of its common stock at a price of $3.65 per share and (ii) pre-funded warrants to purchase up to an aggregate of 4,931,507 shares of common stock at a price of $3.649 per pre-funded warrant.
ELDN Ratings Summary
ELDN Quant Ranking